Table 2.

Adverse events applied in the analysis

	Empagliflozin	Oral semaglutide	Source
NSHE rate, per 100 patient–years	9.535	10.976	Rodbard et al. 2019 [22]
SHE1 rate, per 100 patient–years	0.244	0.244	Rodbard et al. 2019 [22]
SHE2 rate, patient–years	0	0	Rodbard et al. 2019 [22]

NSHE non-severe hypoglycaemia rate, SHE1 severe hypoglycaemia rate (not requiring medical assistance), SHE2 severe hypoglycaemia rate (requiring medical assistance)